The difficult part of introducing radiology AI is often deciding how the output will change the work. A model can process an examination successfully while the facility still experiences delayed reports, duplicate tasks or unanswered questions. Implementation needs a defined owner and a measurable problem.
This guide focuses on the transition from evaluation to routine use. For the underlying types of AI, start with what radiology AI does.
Choose one problem with a clear baseline
Identify the stage you want to improve: finding detection on an eligible examination, a repetitive measurement, draft preparation or report consistency. Record how the task currently works, which people are involved and which failures matter clinically or operationally.
Avoid combining every desired outcome into the first pilot. A detection trial, a documentation trial and a turnaround initiative answer different questions. Define the eligible studies and the result that would justify expansion before the pilot begins.
Set up clinical and operational ownership
| Owner | Decisions to resolve |
|---|---|
| Clinical lead | Intended use, review responsibilities, acceptable performance and handling of significant discrepancies. |
| IT and integration | Input routing, output display, identity matching, downtime and version management. |
| Operations | Queue changes, support, training and the effect on other tasks. |
| Privacy and security | Data flow, access, retention, supplier terms and approved use of patient information. |
Request the exact product documentation and relevant FDA authorization information. The review should establish the permitted use of the deployed version; a vendor’s broad AI portfolio is not the unit of approval.
Test workflow before measuring benefit
Confirm that eligible studies reach the tool and ineligible studies are handled correctly. Check where the result appears, whether it is available before the intended decision, and how users distinguish a negative result from missing or failed processing.
Test identity matching, laterality, priors where applicable, duplicated studies and corrected data. Demonstrate the fallback when the model or network is unavailable. A pilot should not silently remove the pre-existing clinical process before the replacement has been accepted.
Train on limitations as well as controls
Show staff examples of appropriate use, incorrect output and uncertainty. Explain what to do when they disagree and how to report a problem. A busy reader should not have to decide whether a blank AI panel means “normal,” “unsupported” or “not processed.”
Measure the effort of using the tool. Additional clicks, alert review and troubleshooting can offset time saved elsewhere. Ask participants about workload while keeping a separate record of actual use and measured task time.
Evaluate a comparable set of cases
Compare like examinations, users, shifts and complexity. Track exclusions, adoption and missing output so a result is not based only on the easiest successful cases. Review both clinically meaningful errors and workflow burden; a faster draft is not necessarily a faster final report.
The ACR Assess-AI program illustrates the importance of monitoring AI in clinical use rather than stopping at a predeployment result. Your own monitoring should identify the product version and the setting in which it is operating.
Make expansion a decision, not an automatic next step
Summarize what improved, what did not, which issues remain and who owns them. Expand only into an examination or setting for which the intended use, evidence and operating process are appropriate. A new site, scanner population or model update may warrant additional review.
For a facility choosing a reading partner, ask the provider to demonstrate these controls within its service. Natoe’s technology page shows the connected workflow; a facility enquiry can start the discussion about your specific coverage and implementation requirements.
